» Articles » PMID: 7484579

Imaging of Intrahepatic Cholangiocarcinoma: 1. Peripheral Cholangiocarcinoma

Overview
Specialties Oncology
Radiology
Date 1995 Dec 1
PMID 7484579
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cholangiocarcinoma is the second most common primary hepatic malignant tumor after hepatocellular carcinoma, accounting for 5-30% of all primary hepatic malignant tumors [1]. Intrahepatic cholangiocarcinomas can be classified as peripheral cholangiocarcinoma, which originates from an interlobular biliary duct, or as hilar cholangiocarcinoma, which originates from a main hepatic duct or from the bifurcation of the common hepatic duct. Intrahepatic cholangiocarcinomas account for only about half of cholangiocarcinomas, and this pictorial essay focuses only on the peripheral form of the disease. Clinically, therapeutically, and radiologically, these two types of cholangiocarcinomas differ. Features suggestive of the diagnosis of peripheral cholangiocarcinoma can be shown by sonography, CT, and MR imaging. Cholangiography and angiography have a limited role in evaluating this neoplasm that manifests as a focal mass. This essay reviews the appearances of peripheral cholangiocarcinoma and discusses the various imaging techniques that can be used to evaluate this unusual tumor that is often resectable and potentially curable.

Citing Articles

Cholangiocarcinoma: Consistent clinical, cytological, hematological, and biochemical findings and pathomorphology of the liver and kidney in five exotic dog breeds in Abeokuta, Nigeria.

Mshelbwala F, Ajayi O, Adebiyi A, Olaniyi M, Oladipo T, Okpe E Vet World. 2024; 17(9):2053-2061.

PMID: 39507797 PMC: 11536740. DOI: 10.14202/vetworld.2024.2053-2061.


Role of liver biopsy in hepatocellular carcinoma.

Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A World J Gastroenterol. 2019; 25(40):6041-6052.

PMID: 31686761 PMC: 6824282. DOI: 10.3748/wjg.v25.i40.6041.


Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?.

Koay E, Odisio B, Javle M, Vauthey J, Crane C Hepatobiliary Surg Nutr. 2017; 6(2):105-116.

PMID: 28503558 PMC: 5411273. DOI: 10.21037/hbsn.2017.01.16.


Recurrent Cardiac Tamponade: An Unusual Presentation of Intrahepatic Cholangiocarcinoma.

Diaz L, Corral J, Arosemena L, Garcia-Buitrago M, Madrazo B, Martin P ACG Case Rep J. 2016; 3(3):205-8.

PMID: 27144206 PMC: 4843158. DOI: 10.14309/crj.2016.51.


Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

Gulamhusein A, Eaton J, Tabibian J, Atkinson E, Juran B, Lazaridis K Am J Gastroenterol. 2016; 111(5):705-11.

PMID: 27002801 PMC: 5027894. DOI: 10.1038/ajg.2016.55.